![Christoph Brackmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christoph Brackmann
Director of Finance/CFO at
NOVOCURE LIMITED
Net worth: 3 M $ as of 31/05/2026
Profile
Christoph Brackmann is Chief Financial Officer at NovoCure Ltd. since 2025.
Former roles include Global Head-IR & Head-Finance International at Shire Plc from 2017 to 2018, and Senior Vice President-Finance at Moderna, Inc. Education includes an undergraduate degree from the University of Mannheim and an MBA from SDA Bocconi School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD. 0.16% | 06/04/2026 | 188,144 ( 0.16% ) | 3 M $ | 31/05/2026 |
Christoph Brackmann active positions
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Director of Finance/CFO | 01/01/2025 |
Former positions of Christoph Brackmann
| Companies | Position | End |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | - |
| SHIRE | Public Communications Contact | - |
Training of Christoph Brackmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
SDA Bocconi School of Management
 SDA Bocconi School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
- Stock Market
- Insiders
- Christoph Brackmann
